M7T Share Price Performance
AU$0.29
-0.05 (-13.43%)
33.6% undervalued intrinsic discount
AU$0.44
Fair Value
Price AU$0.29
AnalystHighTarget AU$0.44
AnalystConsensusTarget AU$0.69
Fair ValueAU$0.44
Share Pricen/a
Narrative Update • Jun 26
Mach7 Technologies Limited Stock Price
- 2 Narratives written by author
- 0 Comments on narratives written by author
- 16 Fair Values set on narratives written by author
M7T Community Narratives
AN
Fair Value
·Fair Value AU$0.44 33.6% undervalued intrinsic discount
Enterprise Imaging Expansion And AI Adoption Will Drive Powerful Long Term Upside Potential
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value AU$0.69 57.7% undervalued intrinsic discount
Enterprise Imaging And AI Adoption Will Support A Long-Term Upswing For This Healthcare Vendor
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Enterprise Imaging Expansion And AI Adoption Will Drive Powerful Long Term Upside Potential
Hospitals are moving away from patchwork imaging systems, and the growing use of AI in medical scans could favor Mach7’s software that helps health networks connect and use imaging data in one place. The upside depends on whether the company’s reset in sales and delivery turns into bigger, stickier customer rollouts before costs and complexity catch up.Read more
AN
AU$0.44
33.6% undervalued intrinsic discount
Fair Value
Profit Margin
12.57%
Future PE
27.84x
Price in 2029
AU$0.55
Enterprise Imaging And AI Adoption Will Support A Long-Term Upswing For This Healthcare Vendor
Catalysts About Mach7 Technologies Mach7 Technologies provides mission critical enterprise imaging software that helps health systems manage, route and view medical images across departments and locations. What are the underlying business or industry changes driving this perspective?Read more
AN
AU$0.69
57.7% undervalued intrinsic discount
Fair Value
Profit Margin
18.05%
Future PE
23.05x
Price in 2029
AU$0.87
Trending Discussion
Recently Updated Narratives
AN
M7T: Enterprise Imaging Pipeline Will Drive Future Upside Despite Near-Term Revenue Headwinds
Fair Value: AU$0.44 33.6% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Enterprise Imaging And AI Adoption Will Support A Long-Term Upswing For This Healthcare Vendor
Fair Value: AU$0.69 57.7% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Mach7 Technologies Limited Key Details
About M7T
- Founded
- 2007
- Employees
- n/a
- CEO
- WebsiteView website
Mach7 Technologies Limited develops and commercializes medical imaging and data management software solutions for healthcare organizations in North America, the Asia Pacific, the Middle East, Europe, and internationally. It offers eUnity enterprise diagnostic viewer, a zero-footprint viewer that allows medical professionals to remotely access patients’ medical images; vendor-neutral archive (VNA), a vendor-agnostic data management solution, which includes administration tools that allow for the storage, access, retrieval, and viewing of images across a healthcare network. The company also provides workflow applications, such as a universal worklist, quality control (QC) tools designed for technologists’ workflows; image sharing and exchange capabilities; teleradiology services; and additional specialized tools to serve departmental patient care needs. Mach7 Technologies Limited was founded in 2007 and is headquartered in South Burlington, Vermont.
